These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 1379912

  • 1. Alglucerase. A review of its therapeutic use in Gaucher's disease.
    Whittington R, Goa KL.
    Drugs; 1992 Jul; 44(1):72-93. PubMed ID: 1379912
    [Abstract] [Full Text] [Related]

  • 2. [Alglucerase treatment of type I Gaucher's disease. Preliminary results in Spain. Spanish Group on Gaucher's Disease].
    Pérez-Calvo JI, Giraldo P, Giralt M.
    Sangre (Barc); 1997 Jun; 42(3):189-94. PubMed ID: 9381260
    [Abstract] [Full Text] [Related]

  • 3. Individualised low-dose alglucerase therapy for type 1 Gaucher's disease.
    Hollak CE, Aerts JM, Goudsmit R, Phoa SS, Ek M, van Weely S, von dem Borne AE, van Oers MH.
    Lancet; 1995 Jun 10; 345(8963):1474-8. PubMed ID: 7769902
    [Abstract] [Full Text] [Related]

  • 4. Gaucher's disease: a review.
    Morales LE.
    Ann Pharmacother; 1996 Apr 10; 30(4):381-8. PubMed ID: 8729893
    [Abstract] [Full Text] [Related]

  • 5. Alglucerase. A pharmacoeconomic appraisal of its use in the treatment of Gaucher's disease.
    Whittington R, Goa KL.
    Pharmacoeconomics; 1995 Jan 10; 7(1):63-90. PubMed ID: 10155294
    [Abstract] [Full Text] [Related]

  • 6. Gaucher's disease in pregnancy.
    Rosnes JS, Sharkey MF, Veille JC, Mueller-Heubach E.
    Obstet Gynecol Surv; 1996 Sep 10; 51(9):549-58. PubMed ID: 8873155
    [Abstract] [Full Text] [Related]

  • 7. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.
    Barton NW, Brady RO, Dambrosia JM, Di Bisceglie AM, Doppelt SH, Hill SC, Mankin HJ, Murray GJ, Parker RI, Argoff CE.
    N Engl J Med; 1991 May 23; 324(21):1464-70. PubMed ID: 2023606
    [Abstract] [Full Text] [Related]

  • 8. A less costly regimen of alglucerase to treat Gaucher's disease.
    Figueroa ML, Rosenbloom BE, Kay AC, Garver P, Thurston DW, Koziol JA, Gelbart T, Beutler E.
    N Engl J Med; 1992 Dec 03; 327(23):1632-6. PubMed ID: 1435900
    [Abstract] [Full Text] [Related]

  • 9. Quantitative analysis of the targeting of mannose-terminal glucocerebrosidase. Predominant uptake by liver endothelial cells.
    Bijsterbosch MK, Donker W, van de Bilt H, van Weely S, van Berkel TJ, Aerts JM.
    Eur J Biochem; 1996 Apr 15; 237(2):344-9. PubMed ID: 8647071
    [Abstract] [Full Text] [Related]

  • 10. [Therapeutic targets in Gaucher's disease].
    Giraldo P, Roca M.
    Med Clin (Barc); 2011 Sep 15; 137 Suppl 1():46-9. PubMed ID: 22230126
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enzyme replacement therapy for Gaucher's disease.
    Beutler E.
    Baillieres Clin Haematol; 1997 Dec 15; 10(4):751-63. PubMed ID: 9497862
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Gaucher's disease and pregnancy.
    Fasouliotis SJ, Ezra Y, Schenker JG.
    Am J Perinatol; 1998 May 15; 15(5):311-8. PubMed ID: 9643638
    [Abstract] [Full Text] [Related]

  • 15. First long-term results of imiglucerase therapy of type 1 Gaucher disease.
    Niederau C, vom Dahl S, Häussinger D.
    Eur J Med Res; 1998 Feb 21; 3(1-2):25-30. PubMed ID: 9512964
    [Abstract] [Full Text] [Related]

  • 16. Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatment.
    Zimran A, Elstein D, Kannai R, Zevin S, Hadas-Halpern I, Levy-Lahad E, Cohen Y, Horowitz M, Abrahamov A.
    Am J Med; 1994 Jul 21; 97(1):3-13. PubMed ID: 8030654
    [Abstract] [Full Text] [Related]

  • 17. Gaucher's disease in Lithuania: its diagnosis and treatment.
    Kleinotienė G, Tylki-Szymanska A, Czartoryska B.
    Medicina (Kaunas); 2011 Jul 21; 47(7):405-11. PubMed ID: 22112991
    [Abstract] [Full Text] [Related]

  • 18. [Persistence of pulmonary lesions in a 6-year-old boy with type I Gaucher's disease treated by alglucerase since the age of 20 months].
    Versteegh C, Avni F, Cuvelier P, Ferster A.
    Arch Pediatr; 1998 Dec 21; 5(12):1341-3. PubMed ID: 9885741
    [Abstract] [Full Text] [Related]

  • 19. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy.
    Mazher W, Ali J, Abubakar S, Basar S, Murtaza G.
    J Ayub Med Coll Abbottabad; 2018 Dec 21; 30(3):479-481. PubMed ID: 30465391
    [Abstract] [Full Text] [Related]

  • 20. Taliglucerase alfa for the treatment of Gaucher's disease.
    Haddley K.
    Drugs Today (Barc); 2012 Aug 21; 48(8):525-32. PubMed ID: 22916340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.